We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celoxica | LSE:CXA | London | Ordinary Share | GB00B0L9TZ33 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.20 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:6211F Celoxica Holdings PLC 12 October 2007 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached CELOXICA HOLDINGS PLC 2. Reason for the notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights (X) An acquisition or disposal of financial instruments which may ( ) result in the acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights ( ) Other (specify): ( ) 3. Full name of person(s) subject to the notification obligation: Advent Venture Partners LLP 4. Full name of shareholder(s) (if different from 3.) (NB abbreviation noted in brackets) Advent Private Equity Fund III 'A' (APEF3A); Advent Private Equity Fund III 'B' (APEF3B); Advent Private Equity Fund III 'C' (APEF3C); Advent Private Equity Fund III 'D' (APEF3D); Advent Private Equity Fund III GmbH & Co KG (APEF3KG); Advent Private Equity Fund III Affiliates (APEF3Aff); Advent Management III Limited Partnership (AM3LP) 5. Date of the transaction (and date on which the threshold is crossed or reached if different): 10 Oct 2007 6. Date on which issuer notified: 11 Oct 2007 7. Threshold(s) that is/are crossed or reached: 24 % 8. Notified details: A. Voting rights attached to shares Class/type of shares (if possible using the Ordinary (GB00B0L9TZ33) ISIN code) Situation previous to Resulting situation after the triggering transaction the triggering transaction Number of Number Number Number of voting % of voting rights Shares of of rights Voting shares Rights Direct Direct Indirect Direct Indirect 20,735,553* 20,735,553* 24.594%* *: comprised *: comprised *: comprised of of of: APEF3A: APEF3A: APEF3A: 10,492,939 10,492,939 12.446% APEF3B: APEF3B: APEF3B: 5,141,609 5,141,609 6.099% APEF3C: 1,434,234 APEF3C: APEF3C: 1,434,234 1.701% APEF3D: 2,821,118 APEF3D: APEF3D: 2,821,118 3.346% APEF3KG: APEF3KG: APEF3KG: 405,914 405,914 0.481% APEF3Aff: APEF3Aff: APEF3Aff: 338,263 338,263 0.401% AM3LP: AM3LP: AM3LP: 101,476 101,476 0.120% B. Financial Instruments Resulting situation after the triggering transaction Type of Expiration Exercise/ Number of voting % of voting financial date Conversion Period/ rights that may rights instrument Date be acquired if the instrument is exercised/ converted n/a Total (A+B) Number of voting rights % of voting rights Refer A above 9. Chain of controlled undertakings through which the voting rights and/ or the financial instruments are effectively held, if applicable: Advent Venture Partners LLP owns 100% of Advent Limited. Advent Limited owns 100% of Advent Private Equity GmbH, which is the general partner of Advent Private Equity Fund III GMBH & CO KG. Advent Limited also owns 100% of Advent Management III Limited, which is the general partner of Advent Management III Limited Partnership, which is general partner of each of Advent Private Equity Fund III 'A' Limited Partnership, Advent Private Equity Fund III 'B' Limited Partnership, Advent Private Equity Fund III 'C' Limited Partnership, Advent Private Equity Fund III 'D' Limited Partnership and Advent Private Equity Fund III Affiliates Limited Partnership. Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: 14: Contact name: Leslie Gabb, Finance Partner 15. Contact telephone number: +44 20 7932 2100 This information is provided by RNS The company news service from the London Stock Exchange END HOLGUGPCUUPMGUP
1 Year Celoxica Chart |
1 Month Celoxica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions